Redness Reduction & Soothing

Objectively quantify the anti-redness effect of your treatment through AI chromatic analysis, skin comfort measurement, and monitoring of skin reactivity.

The Client Problem

A dermocosmetic brand specializing in sensitive skin is developing a soothing anti-redness cream and must prove its effectiveness on diffuse redness and mild rosacea.

Redness is a common skin concern but difficult to assess objectively. Self-assessments are heavily biased by emotional state and lighting. The brand needs objective instrumental measurements to position itself against the segment leaders.

The identified challenges

  • Objectively measure redness reduction (chromatic analysis)
  • Assess the soothing effect and the reduction of skin reactivity
  • Quantify perceived comfort and quality of life
  • Demonstrate effectiveness under skin stress conditions (cold, UV)
Soothing anti-redness care

Multi-criteria anti-redness evaluation

200Participants
4Countries
42Days
2Skin challenges

Sensitive & Reactive Skin Panel

Women aged 25-60 presenting diffuse redness or diagnosed mild rosacea.

🇫🇷France50 participants
🇩🇪Germany50 participants
🇨🇦Canada50 participants
🇸🇪Sweden50 participants

Protocol with Skin Challenge

Measurement at baseline + after provocation (cold, capsaicin) to assess the protective effect.

01

Chromatic baseline

Standardized photos, AI mapping of the skin's a* (red axis)

02

Daily use (42 days)

Twice-daily application, weekly photos, comfort journal

03

Cold challenge

Controlled exposure to cold (5°C, 10 min): measurement of reactivity before/after treatment

04

Assessment & emotional experience

Final mapping of redness, comfort score, avatar interview on quality of life

Chromatic and sensory analysis

AI Chromatic Analysis

Pixel-by-pixel mapping of the a* axis (red-green) in Lab color space to objectively quantify redness.

Average a* indexRed areaMax intensity

Reactivity Test

Measurement of the vascular response after challenge (cold, capsaicin).

Recovery timeReaction intensity

Comfort & Sensations

Comfort scales: tightness, tingling, warmth, dryness.

Comfort scoreSensations

Quality of Life

Impact of redness on daily life via conversational avatar.

Social discomfortConfidence

Conversational Avatar

AI-guided interview to collect declared perceptions.

Overall satisfaction Repurchase intention

A soothed skin, redness under control

-61% of visible redness surface at D42, AI chromatic measurement

a* Index (redness)

-61%

61% reduction in the average a* index on affected areas at D42 (p<0.001).

Cold reactivity

-54%

After treatment, vascular response to the cold challenge is reduced by 54%. Recovery time halved.

Skin comfort

+67%

Tightness disappeared in 89% of participants. Average comfort score: 9.1/10.

Social discomfort

-72%

72% reduction in the social discomfort score related to redness (adapted DLQI scale).

Results by climate

🇸🇪

Sweden (cold)

a* reduction-65%
Comfort9.3/10
🇫🇷

France (temperate)

a* reduction-59%
Comfort9.0/10
🇨🇦

Canada (continental)

a* reduction-63%
Comfort9.2/10

Scientifically proven anti-redness claims

Validated

"Reduces redness by 61% in 6 weeks"

AI chromatic analysis, 200 participants, 4 countries (p<0.001)

Validated

"Protects the skin against the effects of cold"

-54% vascular reactivity to the cold challenge, controlled test

Validated

"Immediate comfort, 89% without tightness"

Tightness disappeared as early as day 7, comfort score 9.1/10

Validated

"Effective in all climates"

Significant results in cold, temperate, and continental climates

Are you developing an anti-redness skincare product?

Let’s prove its effectiveness together with objective chromatic measurements and resistance tests.

We use cookies to improve your experience on our site. By continuing to browse, you agree to our use of cookies.

Manage your cookie preferences

Essential cookies
Necessary for the site to function. Cannot be disabled.
Analytics cookies
Help us understand how you use the site.
Marketing cookies
Used to provide you with relevant ads.